Manual lymphatic drainage for breast cancer-related lymphoedema.
Identifieur interne : 000387 ( Main/Exploration ); précédent : 000386; suivant : 000388Manual lymphatic drainage for breast cancer-related lymphoedema.
Auteurs : Y. Shao [République populaire de Chine] ; D-S Zhong [République populaire de Chine]Source :
- European journal of cancer care [ 1365-2354 ] ; 2017.
Abstract
Breast cancer-related lymphoedema (BCRL) is a common sequela of surgical or radiation therapy of breast cancer. Although being an important part of conservative therapy, the role of manual lymphatic drainage (MLD) on BCRL is still debating. The objective of the current systematic review and meta-analysis was to determine whether the addition of MLD to the standard therapy (ST) could manage BCRL more effectively. We searched PubMed, EMBASE and Cochrane Library for related randomised clinical trials to compare the volume reduction, improvement of symptoms and arm function between groups with or without MLD. Four randomised controlled trials, with 234 patients, were included. Results showed there was a significant difference in volume reduction between MLD plus routine treatment and sole routine treatment. Current trials show that adding MLD to the ST could enhance the effectiveness of treating volume reduction of lymphoedema, but might not improve subjective symptoms or arm function.
DOI: 10.1111/ecc.12517
PubMed: 27167238
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000831
- to stream PubMed, to step Curation: 000831
- to stream PubMed, to step Checkpoint: 000831
- to stream Ncbi, to step Merge: 008277
- to stream Ncbi, to step Curation: 008277
- to stream Ncbi, to step Checkpoint: 008277
- to stream Main, to step Merge: 000387
- to stream Main, to step Curation: 000387
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Manual lymphatic drainage for breast cancer-related lymphoedema.</title>
<author><name sortKey="Shao, Y" sort="Shao, Y" uniqKey="Shao Y" first="Y" last="Shao">Y. Shao</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Tianjin Medical University General Hospital, Tianjin, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Oncology, Tianjin Medical University General Hospital, Tianjin</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhong, D S" sort="Zhong, D S" uniqKey="Zhong D" first="D-S" last="Zhong">D-S Zhong</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Tianjin Medical University General Hospital, Tianjin, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Oncology, Tianjin Medical University General Hospital, Tianjin</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27167238</idno>
<idno type="pmid">27167238</idno>
<idno type="doi">10.1111/ecc.12517</idno>
<idno type="wicri:Area/PubMed/Corpus">000831</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000831</idno>
<idno type="wicri:Area/PubMed/Curation">000831</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000831</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000831</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000831</idno>
<idno type="wicri:Area/Ncbi/Merge">008277</idno>
<idno type="wicri:Area/Ncbi/Curation">008277</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">008277</idno>
<idno type="wicri:Area/Main/Merge">000387</idno>
<idno type="wicri:Area/Main/Curation">000387</idno>
<idno type="wicri:Area/Main/Exploration">000387</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Manual lymphatic drainage for breast cancer-related lymphoedema.</title>
<author><name sortKey="Shao, Y" sort="Shao, Y" uniqKey="Shao Y" first="Y" last="Shao">Y. Shao</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Tianjin Medical University General Hospital, Tianjin, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Oncology, Tianjin Medical University General Hospital, Tianjin</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhong, D S" sort="Zhong, D S" uniqKey="Zhong D" first="D-S" last="Zhong">D-S Zhong</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Tianjin Medical University General Hospital, Tianjin, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Oncology, Tianjin Medical University General Hospital, Tianjin</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">European journal of cancer care</title>
<idno type="eISSN">1365-2354</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Breast cancer-related lymphoedema (BCRL) is a common sequela of surgical or radiation therapy of breast cancer. Although being an important part of conservative therapy, the role of manual lymphatic drainage (MLD) on BCRL is still debating. The objective of the current systematic review and meta-analysis was to determine whether the addition of MLD to the standard therapy (ST) could manage BCRL more effectively. We searched PubMed, EMBASE and Cochrane Library for related randomised clinical trials to compare the volume reduction, improvement of symptoms and arm function between groups with or without MLD. Four randomised controlled trials, with 234 patients, were included. Results showed there was a significant difference in volume reduction between MLD plus routine treatment and sole routine treatment. Current trials show that adding MLD to the ST could enhance the effectiveness of treating volume reduction of lymphoedema, but might not improve subjective symptoms or arm function.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Tianjin</li>
</settlement>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Shao, Y" sort="Shao, Y" uniqKey="Shao Y" first="Y" last="Shao">Y. Shao</name>
</noRegion>
<name sortKey="Zhong, D S" sort="Zhong, D S" uniqKey="Zhong D" first="D-S" last="Zhong">D-S Zhong</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000387 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000387 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:27167238 |texte= Manual lymphatic drainage for breast cancer-related lymphoedema. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27167238" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |